University of Tennessee Health Science Center UTHSC Digital Commons Theses and Dissertations (ETD) College of Graduate Health Sciences 5-2015 Design, Development and Evaluation of Erlotinib- Loaded Hybrid Nanoparticles for Targeted Drug Delivery to NonSmall Cell Lung Cancer Bivash Mandal University of Tennessee Health Science Center Follow this and additional works at: https://dc.uthsc.edu/dissertations Part of the Pharmaceutics and Drug Design Commons Recommended Citation Mandal, Bivash , "Design, Development and Evaluation of Erlotinib-Loaded Hybrid Nanoparticles for Targeted Drug Delivery to NonSmall Cell Lung Cancer" (2015). Theses and Dissertations (ETD). Paper 166. http://dx.doi.org/10.21007/etd.cghs.2015.0196. This Dissertation is brought to you for free and open access by the College of Graduate Health Sciences at UTHSC Digital Commons. It has been accepted for inclusion in Theses and Dissertations (ETD) by an authorized administrator of UTHSC Digital Commons. For more information, please contact
[email protected]. Design, Development and Evaluation of Erlotinib-Loaded Hybrid Nanoparticles for Targeted Drug Delivery to NonSmall Cell Lung Cancer Document Type Dissertation Degree Name Doctor of Philosophy (PhD) Program Pharmaceutical Sciences Research Advisor George C. Wood, Ph.D. Committee Himanshu Bhattacharjee, Ph.D. James R. Johnson, Ph.D. Timothy D. Mandrell, Ph.D. Duane D. Miller, Ph.D. DOI 10.21007/etd.cghs.2015.0196 This dissertation is available at UTHSC Digital Commons: https://dc.uthsc.edu/dissertations/166 Design, Development and Evaluation of Erlotinib-Loaded Hybrid Nanoparticles for Targeted Drug Delivery to Non-Small Cell Lung Cancer A Dissertation Presented for The Graduate Studies Council The University of Tennessee Health Science Center In Partial Fulfillment Of the Requirements for the Degree Doctor of Philosophy From The University of Tennessee By Bivash Mandal May 2015 Portions of Chapter 1 © 2013 by Elsevier.